AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35291433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 32081236 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 358
Study 32081236 — intervention group
Group type: COMPARATOR
Intervention: PTA
Number of subjects: 358
Study 35729759 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg oral dose)
Number of subjects: 10
Study 35729759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34158376 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus block (ropivacaine 0.5%; 20 mL unilateral; 16 mL/side bilateral)
Number of subjects: 100
Study 34158376 — intervention group
Group type: COMPARATOR
Intervention: Paravertebral block (ropivacaine 0.5%; 20 mL unilateral; 16 mL/side bilateral)
Number of subjects: 100
Study 34158376 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus block
Number of subjects: 100
Study 34158376 — intervention group
Group type: COMPARATOR
Intervention: Paravertebral block
Number of subjects: 100
Study 32183769 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) with a comprehensive pre-treatment assessment interview
Number of subjects: 300
Study 32183769 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) with guidance from a health educator
Number of subjects: 300
Study 32183769 — intervention group
Group type: COMPARATOR
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) without pre-treatment assessment interview
Number of subjects: 300
Study 32183769 — intervention group
Group type: COMPARATOR
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) without guidance from a health educator
Number of subjects: 300
Study 35729492 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Single Cannulation Technique (MuST)
Number of subjects: 200
Study 35729492 — intervention group
Group type: COMPARATOR
Intervention: Rope-ladder (RL) technique
Number of subjects: 200
Study 32448056 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (8-minute audio recording)
Number of subjects: 0
Study 32448056 — intervention group
Group type: COMPARATOR
Intervention: Audiobook listening (control group)
Number of subjects: 0
Study 32448056 — intervention group
Group type: COMPARATOR
Intervention: Passing the time (control group)
Number of subjects: 0
Study 35049252 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries group (n = 25)
Number of subjects: 50
Study 35049252 — intervention group
Group type: COMPARATOR
Intervention: Healthy group (n = 25)
Number of subjects: 50
Study 33636418 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of fish oil ω‐3 fatty acids daily
Number of subjects: 62
Study 33636418 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of fish oil n‐3 fatty acids and 500 mL of reduced‐calorie cranberry juice daily
Number of subjects: 62
Study 33636418 — intervention group
Group type: COMPARATOR
Intervention: Typical diet (Control)
Number of subjects: 62
Study 34480075 — intervention group
Group type: EXPERIMENTAL
Intervention: trichlormethiazide
Number of subjects: 10
Study 35998767 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced online training incorporating additional modules related to externalization and agnosticism
Number of subjects: 140
Study 35998767 — intervention group
Group type: COMPARATOR
Intervention: Standard webinar-based online training
Number of subjects: 140
Study 35998767 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training arms (Enhanced and Standard)
Number of subjects: 140
Study 34639600 — intervention group
Group type: EXPERIMENTAL
Intervention: FIBROWALK plus Treatment-As-Usual (TAU)
Number of subjects: 151
Study 34639600 — intervention group
Group type: COMPARATOR
Intervention: Treatment-As-Usual (TAU)
Number of subjects: 151
Study 32323706 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics administration
Number of subjects: 40
Study 32323706 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 40
Study 36431093 — intervention group
Group type: EXPERIMENTAL
Intervention: Real dry needling
Number of subjects: 60
Study 36431093 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 60
Study 33033863 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model using CT images
Number of subjects: 203
Study 33033863 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 203
Study 33033863 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined logistic model
Number of subjects: 203
Study 35779938 — intervention group
Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 1
Number of subjects: 65
Study 35779938 — intervention group
Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 2
Number of subjects: 65
Study 35779938 — intervention group
Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 3
Number of subjects: 65
Study 35779938 — intervention group
Group type: COMPARATOR
Intervention: Patients responding yes to item 1 vs uncertain/no
Number of subjects: 65
Study 33914661 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF)
Number of subjects: 48
Study 33736696 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART initiation (within 2 weeks after anti-CMV therapy)
Number of subjects: 300
Study 33736696 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation (more than 2 weeks after anti-CMV therapy)
Number of subjects: 300
Study 33736696 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART initiation
Number of subjects: 300
Study 33736696 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation
Number of subjects: 300
Study 35320643 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (4 mg per kilogram of body weight per day tapered over a period of 10 days)
Number of subjects: 800
Study 35320643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 35320643 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 800
Study 34787240 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant low‐laser light therapy
Number of subjects: 40
Study 34787240 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone (topical and compressive treatment)
Number of subjects: 40
Study 32867985 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning frequency of 12 times per day
Number of subjects: 960
Study 32867985 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning frequency of 6 times per day
Number of subjects: 960
Study 32867985 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning frequency of 3 times per day
Number of subjects: 960
Study 32867985 — intervention group
Group type: COMPARATOR
Intervention: Turning frequency of 24 times per day
Number of subjects: 960
Study 34981862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 34981862 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 32015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent coaching intervention
Number of subjects: 71
Study 32015127 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 71
Study 36129087 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 60
Study 36129087 — intervention group
Group type: COMPARATOR
Intervention: Erector spine plane block (ESPB)
Number of subjects: 60
Study 33203537 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band resistance training for 14 weeks
Number of subjects: 42
Study 33203537 — intervention group
Group type: COMPARATOR
Intervention: Control group (passive during intervention)
Number of subjects: 42
Study 33111950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multilevel single-shot thoracic paravertebral blockade (PVB) from T2 to T5
Number of subjects: 218
Study 33111950 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 218
Study 33111950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multilevel single-shot thoracic paravertebral blockade (PVB)
Number of subjects: 218
Study 35904473 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid conditions (n=833)
Number of subjects: 1627
Study 35904473 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid conditions with PGT-A
Number of subjects: 1627
Study 35904473 — intervention group
Group type: COMPARATOR
Intervention: Dry conditions (n=794)
Number of subjects: 1627
Study 33236860 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (INPWT) applied after primary closure of the midline sternotomy (n = 52)
Number of subjects: 104
Study 33236860 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing applied in the control group (n = 52)
Number of subjects: 104
Study 33236860 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (INPWT)
Number of subjects: 104
Study 33236860 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing
Number of subjects: 104
Study 33782092 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence management intervention
Number of subjects: 1186
Study 33782092 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1186
Study 33901231 — intervention group
Group type: EXPERIMENTAL
Intervention: Family annual cash income less than 24000ETB
Number of subjects: 243
Study 33901231 — intervention group
Group type: EXPERIMENTAL
Intervention: History of still birth
Number of subjects: 243
Study 33901231 — intervention group
Group type: EXPERIMENTAL
Intervention: History of abortion
Number of subjects: 243
Study 33901231 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconception tea use
Number of subjects: 243
Study 33901231 — intervention group
Group type: EXPERIMENTAL
Intervention: Pesticides/chemical exposure
Number of subjects: 243
Study 33901231 — intervention group
Group type: COMPARATOR
Intervention: Preconception care
Number of subjects: 243
Study 33901231 — intervention group
Group type: COMPARATOR
Intervention: Taking iron/folic acid/multivitamin during the current pregnancy
Number of subjects: 243
Study 34924513 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigravity treadmill therapy
Number of subjects: 0
Study 34924513 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 32198963 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP catheter group (TAP-C) infused with 0.2% ropivacaine at 10 mL/h
Number of subjects: 70
Study 32198963 — intervention group
Group type: COMPARATOR
Intervention: TAP saline group (TAP-S) infused with saline at 10 mL/h
Number of subjects: 70
Study 36174261 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction condition
Number of subjects: 612
Study 36174261 — intervention group
Group type: COMPARATOR
Intervention: Test-retest control
Number of subjects: 612
Study 34271265 — intervention group
Group type: EXPERIMENTAL
Intervention: HOM-HEMP intervention (experimental groups A and B)
Number of subjects: 213
Study 34271265 — intervention group
Group type: EXPERIMENTAL
Intervention: HOM-HEMP intervention (experimental group B)
Number of subjects: 213
Study 34271265 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study 32100499 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture for 30 min, 5 min before routine local infiltration anesthesia.
Number of subjects: 64
Study 32100499 — intervention group
Group type: COMPARATOR
Intervention: 1% lidocaine for routine local infiltration anesthesia.
Number of subjects: 64
Study 35914911 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 0
Study 35914911 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 35914911 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 0
Study 33535690 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal stimulation at 2 mA for 20 min over F7)
Number of subjects: 29
Study 33535690 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 29
Study 32747302 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine plus bevacizumab as maintenance treatment
Number of subjects: 400
Study 32747302 — intervention group
Group type: COMPARATOR
Intervention: Fluoropyrimidine alone as maintenance treatment
Number of subjects: 400
Study 35395943 — intervention group
Group type: EXPERIMENTAL
Intervention: Auxora
Number of subjects: 261
Study 35395943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 33449848 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic nitrate supplementation (4.03 mmol nitrate and 0.29 mmol nitrite daily for 4 weeks)
Number of subjects: 10
Study 33449848 — intervention group
Group type: COMPARATOR
Intervention: Placebo (devoid of nitrate and nitrite)
Number of subjects: 10
Study 33102416 — intervention group
Group type: EXPERIMENTAL
Intervention: Techno-social innovations aimed at improving father's involvement in child-care
Number of subjects: 0
Study 34453996 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-score
Number of subjects: 300
Study 34453996 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL) label
Number of subjects: 300
Study 34453996 — intervention group
Group type: COMPARATOR
Intervention: No label control condition
Number of subjects: 300
Study 34689055 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-NF
Number of subjects: 59
Study 34689055 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral-NF
Number of subjects: 59
Study 34689055 — intervention group
Group type: COMPARATOR
Intervention: No-NF
Number of subjects: 59
Study 35560262 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial assistance to attend the cancer screening programme
Number of subjects: 412
Study 35560262 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial assistance)
Number of subjects: 412
Study 32887850 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention (six weekly individual physical therapy sessions for lower-extremity exercise and fitness walking; nine biweekly nurse telephone counseling sessions)
Number of subjects: 182
Study 32887850 — intervention group
Group type: COMPARATOR
Intervention: Attention-control intervention (six weekly and nine biweekly nurse telephone sessions on health topics)
Number of subjects: 182
Study 34245081 — intervention group
Group type: EXPERIMENTAL
Intervention: HepB-alum vaccine
Number of subjects: 8138
Study 34245081 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HepB-alum vaccine)
Number of subjects: 8138
Study 34245081 — intervention group
Group type: EXPERIMENTAL
Intervention: HepB-alum vaccination
Number of subjects: 8138
Study 32112114 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil (3 μg/kg) + propofol (2.5 mg/kg)
Number of subjects: 70
Study 32112114 — intervention group
Group type: COMPARATOR
Intervention: sufentanil (0.3 μg/kg) + propofol (2.5 mg/kg)
Number of subjects: 70
Study 36214061 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% minoxidil combined with microneedling (weekly)
Number of subjects: 40
Study 36214061 — intervention group
Group type: COMPARATOR
Intervention: 2% minoxidil (control group)
Number of subjects: 40
Study 36214061 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (microneedling + minoxidil)
Number of subjects: 40
Study 36214061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 34482089 — intervention group
Group type: EXPERIMENTAL
Intervention: CAC-disclosed group (atorvastatin treatment)
Number of subjects: 450
Study 34482089 — intervention group
Group type: COMPARATOR
Intervention: CAC-blinded group (risk factor education only)
Number of subjects: 450
Study 33569725 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance colonoscopy at 3, 6, 12, and 24 months after p-EMR (group A; n = 90)
Number of subjects: 180
Study 33569725 — intervention group
Group type: COMPARATOR
Intervention: Surveillance colonoscopy at 6, 12, and 24 months after p-EMR (group B; n = 90)
Number of subjects: 180
Study 33609618 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured clinical algorithm for scheduled counselling, glucose monitoring, and adjustment of medication
Number of subjects: 150
Study 33609618 — intervention group
Group type: COMPARATOR
Intervention: Routine diabetes management (control)
Number of subjects: 150
Study 33609618 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured clinical algorithm
Number of subjects: 150
Study 32360129 — intervention group
Group type: EXPERIMENTAL
Intervention: Active warming method
Number of subjects: 64
Study 32360129 — intervention group
Group type: COMPARATOR
Intervention: Routine care via a cotton blanket
Number of subjects: 64
Study 35302688 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl aspartyl glutamic acid (4.9%, NAAGA)
Number of subjects: 24
Study 35302688 — intervention group
Group type: COMPARATOR
Intervention: Fluorometholone (0.1%, FM)
Number of subjects: 24
Study 33176772 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health assessment using WHO Oral Health Assessment form 1997 and WHO oral health assessment questionnaire for adult/children 2013
Number of subjects: 310
Study 33176772 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of treatment needs
Number of subjects: 310
Study 33902550 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylene mesh
Number of subjects: 24
Study 33902550 — intervention group
Group type: COMPARATOR
Intervention: Custom-made acrylic stent
Number of subjects: 24
Study 32205704 — intervention group
Group type: COMPARATOR
Intervention: BrAIST (TLSO)
Number of subjects: 238
Study 32205704 — intervention group
Group type: EXPERIMENTAL
Intervention: ISICO (SPoRT braces with or without SEAS exercises)
Number of subjects: 238
Study 36449318 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5-day training on managing common child mental health problems
Number of subjects: 389
Study 36449318 — intervention group
Group type: COMPARATOR
Intervention: Refresher training on identification and referral
Number of subjects: 389
Study 32918607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-assisted empowerment program
Number of subjects: 74
Study 32711393 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 57
Study 32711393 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent training with resistive equipment (CTRE)
Number of subjects: 57
Study 32711393 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent training with multiple sets (CTMS)
Number of subjects: 57
Study 35131037 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 2·4 mg
Number of subjects: 401
Study 35131037 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 1·7 mg
Number of subjects: 401
Study 35131037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study 33371109 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI)
Number of subjects: 100
Study 33371109 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study 34099328 — intervention group
Group type: EXPERIMENTAL
Intervention: IHV01 vaccine (75 µg, 150 µg, and 300 µg doses)
Number of subjects: 65
Study 34099328 — intervention group
Group type: EXPERIMENTAL
Intervention: IHV01 vaccine
Number of subjects: 65
Study 34099328 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 65
Study 32419935 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of oral dexamethasone 0.3 mg/kg (maximum 12 mg)
Number of subjects: 60
Study 32419935 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 0.6 mg/kg/day for 2 days (maximum 16 mg/day)
Number of subjects: 60
Study 32419935 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone 1.5 mg/kg/day for 5 days (maximum 60 mg/day)
Number of subjects: 60
Study 32419935 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 34156758 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray-on skin (ReCell)
Number of subjects: 45
Study 34156758 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 45
Study 32737577 — intervention group
Group type: COMPARATOR
Intervention: Oral dexamethasone (2.5 mg on two successive days a week)
Number of subjects: 50
Study 32737577 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (up to 2 g for 180 days)
Number of subjects: 50
Study 32737577 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (dexamethasone and mycophenolate)
Number of subjects: 50
Study 35210348 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of intravenous TXA administered intraoperatively
Number of subjects: 1230
Study 35210348 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) administered intraoperatively
Number of subjects: 1230
Study 33490018 — intervention group
Group type: EXPERIMENTAL
Intervention: HPHB intervention (a combination of health and parenting intervention augmenting routine ultrasound)
Number of subjects: 0
Study 33490018 — intervention group
Group type: COMPARATOR
Intervention: Routine ultrasound (US)
Number of subjects: 0
Study 35191746 — intervention group
Group type: EXPERIMENTAL
Intervention: JS016 plus standard care
Number of subjects: 199
Study 35191746 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 199
Study 33705547 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous estradiol genetically predicted by variants in the CYP19A1 gene region
Number of subjects: 170593
Study 33705547 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants in the JMJD1C gene (predictor of high endogenous testosterone)
Number of subjects: 170593
Study 33880495 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of 1% of SFAs for 1% of linoleic acid
Number of subjects: 1252
Study 33880495 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of 1% of marine n‐3 PUFA DHA for linoleic acid
Number of subjects: 1252
Study 33284796 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal (0.011 ml supplement/kg bodyweight)
Number of subjects: 375
Study 33284796 — intervention group
Group type: EXPERIMENTAL
Intervention: High (0.063 ml supplement/kg bodyweight)
Number of subjects: 375